Harris County, Texas

At a glance

CDC supports Harris County, Texas, and other state and local health departments, or their bona fide agents, through cooperative agreements to support childhood lead poisoning prevention activities. Read about the program's successes.

Texas state sign in the shape of an arrow

About the program

Harris County received $300,000 through cooperative agreement EH21-2102 from the Centers for Disease Control and Prevention (CDC) in FY 2022. The funds address childhood lead poisoning prevention and surveillance programmatic activities being conducted from September 30, 2022, to September 29, 2023.

The strategies focus on community-based approaches for lead hazard elimination and emphasize population-based policy intervention. To learn more about these efforts in Harris Texas, contact the program below.

Harris County Public Health

Environmental Public Health Division

Childhood Lead Poisoning Prevention

201 Caroline St. Ste 460

Houston, TX 77027

Phone: 713-274-6374

Success story: funding year 3

Harris County, Texas, strengthens lead poisoning awareness with media campaigns

Challenge

Lead poisoning continues to be one of the most common and preventable environmental threats to both adults and children, especially those younger than six years old. According to the Texas Department of State Health Services (TX DSHS) in 2022, 790 children under six years old in Harris County were identified with blood lead levels of 5 µg/dL and above. TX DSHS adopted the Centers for Disease Control and Prevention's (CDC) updated blood lead reference value of 3.5 µg/dL on January 1, 2023. Although lead poisoning can pose as an evident threat to an individual's health, many lack awareness of lead poisoning and believe it is a thing of the past.

Intervention

In addition to participating in community outreach events and giving presentations, the Harris County Texas Childhood Lead Poisoning Prevention Program uses media campaigns to educate the public on the sources and risks of lead exposure to address lead toxicity.

Between April 17, 2023, and May 14, 2023, the program launched a billboard campaign in three Harris County areas (ZIP Codes 77503, 77530, and 77547). Two ZIP codes (77503 and 77547) are identified as priority ZIP Codes under the 2019 Texas Childhood Blood Lead Screening Guidelines The billboards' goal was to encourage and promote lead testing among households with children under the age of six years.

In a continued effort to lower lead exposure, the program worked with the Office of Communications, Education and Engagement team to draft a news release for news outlets to use and incorporate into stories for their audience during National Lead Poisoning Prevention Week (NLPPW), which was held from October 22, 2023, to October 28, 2023. Following the news release, the program received an interview request and spoke with Univision, a Spanish-language television network to provide an overview of the dangers of lead exposure and encourage lead testing. Furthermore, during NLPPW, the team produced social media content and pushed it across all social marketing platforms to highlight lead poisoning-related content.

Impact

The billboard campaign proved to be successful, garnering more than 1.9 million impressions —reflecting the number of individuals who passed and viewed the billboard throughout the four-week promotional period spanning from April 17, 2023, to May 14, 2023. Reaching a large audience through media campaigns is essential for creating educational awareness and influencing behavior. Therefore, the program will continue to implement a variety of media outlets to enhance awareness about lead exposure and promote lead testing among families with children under the age of six years who may be unknowingly at risk of lead exposure. Program managers plan to develop a survey to track whether families who requested and received a blood lead test were influenced by the media campaigns.

Funding for this work was made possible in part by Grant NUE2EH001448 from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of CDC; nor does mention of trade names, commercial practices, or organizations or imply endorsement by the U.S. Government.

Success story: funding year 2

Revamping childhood blood lead testing in women, infants, and children (WIC) clinics in Harris County, Texas

Challenge

Higher blood lead levels (BLLs) in children are more likely to occur in areas that are generally below the federal poverty level. The Texas Department of State Health Services (TX DSHS) reported that in 2019, 646 children under the age of six years who received blood lead tests in Harris County had BLLs of 5 µg/dL and above that required follow-up actions. While exposure to lead is still a threat, many families are unaware and are not being encouraged by healthcare professionals to test their children for lead.

Intervention

In 2017, the Lead Testing Program was piloted in two Harris County Public Health (HCPH) Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) clinics located within the Greater Inwood of North Houston and Pasadena communities. The purpose of the pilot program was to increase testing rates amongst these populations who are underserved by raising lead awareness through educational campaigns, outreach and education, and offering lead testing. The pilot proved to be a success as the number of children who were tested for lead through WIC increased by 18% from October 2017 through September 2018. In March of 2020, the number of children who received lead testing at the WIC clinics decreased because of the pandemic.

To continue the collaboration with WIC, the program staff developed a plan to revamp the lead testing program by increasing the number of WIC clinics that offer lead testing. The program currently partners with four HCPH WIC clinics to increase testing and raise awareness of the dangers of lead and how to prevent exposure. Expanding lead testing services to additional WIC sites will give the program a better scope of how many children are exposed to lead.

Impact

Lead testing was successfully implemented in two additional WIC clinics thanks to the program's redesign. Since the Lead Testing Program was modified and reintroduced in November 2022, a lead test has been administered to approximately 1,441 children under the age of six years at the four WIC sites. The established partnership with WIC will continue to improve the number of children who are lead-tested and raise awareness among their parents and households. Additionally, families enrolled in WIC will have the opportunity to obtain their first lead test as well as connections to care for children who are discovered to have blood lead levels of 3.5μg/dL and higher.

Funding for this work was made possible in part by NUE2EH001368 from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Success story: funding year 1

Partnering for childhood blood lead testing in WIC clinics, Harris County, Texas

Challenge

Harris County is home to many industries that produce airborne lead contaminants. Harris County is also home to Guatemalan, Honduran, Salvadoran, and Mexican communities that use traditional ceramic pottery that may be glazed with lead. While the incidence of lead poisoning has gradually declined in the U.S., disparities continue to exist among this economically disadvantaged population in Harris County. Children under 72 months of age are at a higher risk for long-term damage caused by lead poisoning. In 2017, approximately 1.95% (6,767) of children ages ≤ 5 years old in Harris County were considered to have elevated blood lead levels (BLLs). Children eligible for Medicaid are at a higher risk for elevated BLLs. However, blood lead testing is not conducted as a part of routine visits at Women, Infant, and Children (WIC) clinics in Harris County where many of these children are Medicaid-eligible.

Intervention

Due to lack of resources, no targeted childhood lead testing or lead poisoning prevention education had been provided to the underserved populations in the Greater Inwood of North Houston and Pasadena communities. The Harris County Childhood Lead Poisoning Prevention Program (CLPPP) partnered with two Special Supplemental Nutrition Program WIC clinics in Harris County. These clinics were selected because 75% of the children enrolled in WIC are eligible for Medicaid and are at higher risk for elevated blood lead levels.

Additionally, these communities are home to Latin American families that may use lead-based ceramic pots and pans, live in housing located near industries that produce airborne lead contaminants, and live in homes built before 1978. In these communities, the Harris County CLPPP provided lead poisoning awareness education and increased blood lead testing for children. WIC providers received linguistic and culturally appropriate lead education and informational materials to effectively increase lead awareness amongst their patients. After receiving lead poisoning and prevention education, patients at these WIC clinics were also offered additional resources and services.

Impact

Prior to partnering with WIC, 1,803 children in the selected communities were screened for lead exposure. After Harris County CLPPP initiated their educational intervention at the WIC clinics in the Greater Inwood and Pasadena communities, 2,119 children were screened from October 2017 through September 2018. This represents an 18% increase in children served compared to before Harris County CLPPP partnered with WIC. The program plans to extend this intervention to ten additional WIC clinics within its jurisdiction.

Funding for this work was made possible in part by NUE2EH001368 from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.